Actavis to pay Texas $170m in drug pricing case
The court found Actavis and co-defendant Actavis Elizabeth to have misrepresented its drug prices to Medicaid. The decision came after Florida-based pharmacy Ven-a-Care filed a whistleblower lawsuit under
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.